Prostate cancer
Not yet recruitingStudy on Teverelix for Patients with Advanced Prostate Cancer
- Disease:Prostate cancer
- Substances:Teverelix
Lithuania- Participants:18–64 years · 65+ years
- Substances:Teverelix
- Sponsor:Antev Limited
Rare diseases
Investigational molecules
Locations
106 New Bond Street, W1S 1DN, United Kingdom
Antev Limited’s clinical research is centered on advanced prostate cancer, with a clear focus on therapeutic strategies that address disease control in men with advanced-stage malignancy.
The sponsor’s current research activity reflects interest in interventions designed to suppress testosterone and maintain hormonal control in advanced disease settings.
Antev Limited runs clinical trials in conditions such as Prostate cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
LithuaniaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.